Seminar Speaker Bios
Keynote Speaker: Dan M. Roden, M.D.
Assistant Vice Chancellor for Personalized Medicine
Vanderbilt University School of Medicine
Dr. Roden’s research focuses on the mechanisms of variability to drug response in the treatement of cardiac arrhythmias. Dr. Roden directs the Pharmacogenomics of Arrhythmia Therapy (PAT) program, the Vanderbilt site part of the NIH Pharmacogenetics Research Network. His efforts have helped define genetic variations which lead to altered drug treatment responses. He is a Distinguished Scientist of both the American Heart Association and Heart Rhythm Society.
Keynote Speaker: Richard M. Weinshilboum, M.D.
Professor of Medicine and
Professor of Pharmacology
Chair, Department of Pharmacology
Mayo Clinic College of Medicine
Dr. Weinshilboum’s studies the pharmacogenomics of drugs that are used to treat cancer. Dr. Weinshilboum is director of the Pharmacogenetics of Phase II Drug Metabolizing Enzymes program which is part of the NIH Pharmacogenetics Research Network. His research utilizes modern, high throughput genome-wide techniques to increase our understanding of the role of inheritance in individual variation in response to drugs and in the pathophysiology of human diseases. Through his efforts, he has discovered numerous genes that are risk factors for adverse drug reactions or lack of drug effect.